198 related articles for article (PubMed ID: 23233905)
1. Clinical opportunities in combining immunotherapy with radiation therapy.
Finkelstein SE; Fishman M
Front Oncol; 2012; 2():169. PubMed ID: 23233905
[TBL] [Abstract][Full Text] [Related]
2. Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.
Finkelstein SE; Rodriguez F; Dunn M; Farmello MJ; Smilee R; Janssen W; Kang L; Chuang T; Seigne J; Pow-Sang J; Torres-Roca JF; Heysek R; Biagoli M; Shankar R; Scott J; Antonia S; Gabrilovich D; Fishman M
Immunotherapy; 2012 Apr; 4(4):373-82. PubMed ID: 22512631
[TBL] [Abstract][Full Text] [Related]
3. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.
Finkelstein SE; Iclozan C; Bui MM; Cotter MJ; Ramakrishnan R; Ahmed J; Noyes DR; Cheong D; Gonzalez RJ; Heysek RV; Berman C; Lenox BC; Janssen W; Zager JS; Sondak VK; Letson GD; Antonia SJ; Gabrilovich DI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):924-32. PubMed ID: 21398051
[TBL] [Abstract][Full Text] [Related]
4. 50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
Herrera FG; Valerio M; Berthold D; Tawadros T; Meuwly JY; Vallet V; Baumgartner P; Thierry AC; De Bari B; Jichlinski P; Kandalaft L; Coukos G; Harari A; Bourhis J
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):320-334. PubMed ID: 30267761
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial.
Monga V; Miller BJ; Tanas M; Boukhar S; Allen B; Anderson C; Stephens L; Hartwig S; Varga S; Houtman J; Wang L; Zhang W; Jaber O; Thomason J; Kuehn D; Rajput M; Metz C; Zamba KD; Mott S; Abanonu C; Bhatia S; Milhem M
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330766
[TBL] [Abstract][Full Text] [Related]
6. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
7. Combination Treatment of Stereotactic Body Radiation Therapy and Immature Dendritic Cell Vaccination for Augmentation of Local and Systemic Effects.
Choi CW; Jeong MH; Park YS; Son CH; Lee HR; Koh EK
Cancer Res Treat; 2019 Apr; 51(2):464-473. PubMed ID: 29879758
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression.
Huang J; Wang Y; Guo J; Lu H; Lin X; Ma L; Teitz-Tennenbaum S; Chang AE; Li Q
Clin Immunol; 2007 Jun; 123(3):298-310. PubMed ID: 17449328
[TBL] [Abstract][Full Text] [Related]
9. Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination.
Carlson PM; Patel RB; Birstler J; Rodriquez M; Sun C; Erbe AK; Bates AM; Marsh I; Grudzinski J; Hernandez R; Pieper AA; Feils AS; Rakhmilevich AL; Weichert JP; Bednarz BP; Sondel PM; Morris ZS
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36639155
[TBL] [Abstract][Full Text] [Related]
10. Case Report:
Huang JW; Kuo CL; Wang LT; Ma KS; Huang WY; Liu FC; Yang KD; Yang BH
Front Immunol; 2021; 12():752563. PubMed ID: 35003064
[TBL] [Abstract][Full Text] [Related]
11. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.
Rodríguez-Ruiz ME; Perez-Gracia JL; Rodríguez I; Alfaro C; Oñate C; Pérez G; Gil-Bazo I; Benito A; Inogés S; López-Diaz de Cerio A; Ponz-Sarvise M; Resano L; Berraondo P; Barbés B; Martin-Algarra S; Gúrpide A; Sanmamed MF; de Andrea C; Salazar AM; Melero I
Ann Oncol; 2018 May; 29(5):1312-1319. PubMed ID: 29554212
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806).
Isfahanian N; Lukka H; Dayes I; Quan K; Schnarr KL; Douvi G; Goldberg M; Wright J; Swaminath A; Chow T; Diamond K; Cutz JC; Kavsak P; Thabane L; Tsakiridis T
Clin Genitourin Cancer; 2020 Aug; 18(4):e410-e415. PubMed ID: 32265129
[TBL] [Abstract][Full Text] [Related]
13. Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.
Moore C; Hsu CC; Chen WM; Chen BPC; Han C; Story M; Aguilera T; Pop LM; Hannan R; Fu YX; Saha D; Timmerman R
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1306-1316. PubMed ID: 33794306
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Clinical Responses of Neoadjuvant Dendritic Cell Infusions and Radiation in Soft Tissue Sarcoma.
Raj S; Bui MM; Springett G; Conley A; Lavilla-Alonso S; Zhao X; Chen D; Haysek R; Gonzalez R; Letson GD; Finkelstein SE; Chiappori AA; Gabrilovitch DI; Antonia SJ
Sarcoma; 2015; 2015():614736. PubMed ID: 26880867
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial.
Kim YJ; Ahn H; Kim CS; Lee JL; Kim YS
Trials; 2018 Apr; 19(1):212. PubMed ID: 29609646
[TBL] [Abstract][Full Text] [Related]
16. Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy.
Wang YS; Liu SJ; Huang SC; Chang CC; Huang YC; Fong WL; Chi MS; Chi KH
Front Oncol; 2012; 2():149. PubMed ID: 23112956
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma.
Fedorova L; Mudry P; Pilatova K; Selingerova I; Merhautova J; Rehak Z; Valik D; Hlavackova E; Cerna D; Faberova L; Mazanek P; Pavelka Z; Demlova R; Sterba J; Zdrazilova-Dubska L
Front Oncol; 2019; 9():1169. PubMed ID: 31799177
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model.
Freytag SO; Paielli D; Wing M; Rogulski K; Brown S; Kolozsvary A; Seely J; Barton K; Dragovic A; Kim JH
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):873-85. PubMed ID: 12377341
[TBL] [Abstract][Full Text] [Related]
20. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
Kupelian PA; Potters L; Khuntia D; Ciezki JP; Reddy CA; Reuther AM; Carlson TP; Klein EA
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):25-33. PubMed ID: 14697417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
